Why Canopy Growth’s (TSX:WEED) Biggest Investor Isn’t Pleased With Their Results

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) may be the world’s biggest cannabis company by revenue, but their biggest investor is itching for better results

| More on:

Remember Constellation Brands Inc (NYSE:STZ)?

It’s a name that hasn’t come up much lately. But last summer, they were all the rage, as their $5 billion Canopy Growth Corp (TSX:WEED)(NYSE:STZ) investment was the biggest story at the time. The investment triggered a massive bull market in cannabis stocks, which sent all of the major producers soaring before later crashing in the fall bear market.

Since then, it’s been mostly quiet on the Constellation Front. Their investment did infuse Canopy with a giant pile of cash, which it used to finance acquisitions like Acreage Holdings, but other than that, not much has happened… until just recently.

In their Q1 conference call, Constellation executives said that they were not happy with Canopy’s full-year results. An unusually blunt statement for a formal corporate event, it could have serious implications for Canopy’s short term value. Although Constellation executives were quick to point out that they’re still optimistic about Canopy’s long term prospects, their recent statement raises questions about the company’s operations.

Huge net loss

In his Q1 conference call statement, Constellation CEO Bill Newslands said that he was “…not pleased with Canopy’s recent reported year-end results.” Although his statement was vague, Newlands was almost certainly referring to the company’s large and growing net losses.

In Q4, Canopy reported a net loss of $323 million for the quarter and $670 million for the year–both up significantly from the comparable periods a year prior. These massive losses both include non-operating items; however, even the Q4 operating loss was large at $174 million.

Interest expense way up

As a result of the costs it incurred acquiring Canopy, Constellation Brands’ interest expense was up by 31% or $40 million in its most recent quarter. The company is also forecasting total interest expenses of $425-$435 million for 2020.

Of course, a big jump in interest is to be expected: $5 billion is a lot of financing. However, if Canopy isn’t going to turn a profit any time soon, such massive increases are hard to justify, as they eat into Constellation’s profit considerably.

Long term optimism

Despite all the costs they’ve taken on in acquiring Canopy, Constellation’s executives remain optimistic about the investment. In his conference call statement, Newlands said, “We continue to aggressively support Canopy on a more focused, long-term strategy to win markets and form factors that matter, while paving a clear path to profitability.” This indicates that Constellation Brands executives still believe Canopy has a good future ahead of it.

On the other hand, it’s clear that Canopy’s growth can’t continue at the expense of profits forever. Even excluding non-cash items, the company’s losses are often around two times revenue, which isn’t long term sustainable. It would be unfortunate if Canopy spent all the money it received from the Constellation deal without generating profit from it. At the rate the company is burning through cash, though, that just might happen.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »